Transcriptomics

Dataset Information

0

Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [iFLT3-ITD-Depletion_In VITRO]

ABSTRACT: We performed 3'-RNA-Sequencing on RNA isolated from murine MLL-AF9/iFLT3-ITD cells where the inducible iFLT3-ITD transgene had been depleted for 24 or 48 hours compared to non-depleted conditions in vitro to perform differential gene expression analysis.

ORGANISM(S): Mus musculus

PROVIDER: GSE163926 | GEO | 2021/01/13

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [iFLT3-ITD-Depletion_In VIVO]
2021-01-13 | GSE163927 | GEO
Genomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia
2021-01-13 | GSE163932 | GEO
Genomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [iFLT3-ITD-Depletion_In VIVO]
| PRJNA688230 | ENA
Genomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [iFLT3-ITD-Depletion_In VITRO]
| PRJNA688228 | ENA
Genomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia
| PRJNA688227 | ENA
Transcriptomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [MV411_OCI-AML3_DMSO_AC220_24hr]
2021-01-13 | GSE163930 | GEO
Genomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [MV411_OCI-AML3_ATF4_RNAP2_CHIP]
2021-01-13 | GSE163922 | GEO
Genomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [MV411_OCI-AML3_ATF4_RNAP2_CHIP]
| PRJNA688222 | ENA
Genomics Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukaemia [MV411_OCI-AML3_DMSO_AC220_24hr]
| PRJNA688229 | ENA
Transcriptomics Role of NFATc1 in patients with FLT3-ITD AML
2014-09-27 | E-GEOD-61804 | biostudies-arrayexpress